Author: Amanda Greenbrier

Virtus Junxit Telegram Community Please join the channel and make sure notifications are enabled, so you’re the first to know when alerts are published. Virtus Junxit Telegram Facebook Twitter Linkedin  5/5 Monday – March 27, 2023 7:30 AM Good morning and happy Monday! We’re starting the week with a bang by bringing you a low-price and tight float NASDAQ-listed company on our radar: Healthcare Triangle Inc., trading under the ticker $HCTI. Friday’s close was only $0.415! This healthcare information technology company has been turning heads with their suite of software, solutions, platforms, and services that enable organizations to deliver…

Read More

3/6/23 *UPDATE* Greetings Readers, It’s Monday and time to hit the ground running. But before we get too far ahead of ourselves, it’s time to focus our attention back on Nasdaq profile (RNXT). Here’s why… RNXT was able to post a new 52-week high of $5.70 last week, but more importantly, it was able to close above a key psychological support level at $5.00 Friday. With that $5.20 session close, RNXT had its highest close in the last 52-week period. Now this is key. If psychological support grows at the $5.00 level, RNXT could be seeing the building blocks be…

Read More

2/27/23 Greetings Readers, It’s Monday which means I don’t want to take up too much of your time. My last profile, (ATNM), was a solid double-digit, short term champ. Running approximately $1.00+ (11%) from a Tuesday 2/14 open to its Tuesday 2/21 high, it joined the long list of champs I’ve delivered over the last several months. And don’t forget, if you were with us for when I brought ATNM to your attention the morning of October 24th, it has now maxed out a run of approximately 101% to this past Tuesday’s high. Plus, let me give you another reminder…

Read More

Stocks have hit a little turbulence in February after shooting higher in January… (But keep reading to see why we’re not worried ) Wall Street closed another bumpy week with a mixed performance on Friday amid worries that inflation is not cooling as quickly or as smoothly as hoped… The S&P fell 0.3% after pairing a bigger loss from the morning. The Dow Jones Industrial Average rose 129 points, or 0.4%, after coming back from an early loss of 179 points, while the Nasdaq composite fell 0.6%. Stocks have hit turbulence in February after shooting higher in January with hopes…

Read More

2/13/23 Greetings Readers, Friday, huh? Crazy stuff. My latest alert, Hillstream BioPharma, Inc. (HILS), has been an absolute killer since I brought it to your attention. On the morning of January 30th, it opened at $.596. By the end of last week? All it did was nail a stunning February high of $2.65. Its $2.00+ surge has resulted in HILS running approximately 344% in under 2 weeks. That’s nuts. But now it’s time to turn to past champ for Tuesday’s opening bell. At 8:00PM EST tonight, the complete report arrives. Another multi-dollar mover (approx.) after alert, this profile could once…

Read More

Week of February 5, 2023 The monthly jobs report shocks Wall Street by adding 517,000 jobs in January 2023… Big Tech Earnings…the College Dropout that just lost $61B, plus more… All coming up in this week’s Round-up report… The economy wasn’t supposed to add half a million jobs in January. In fact, a consensus poll of 81 economists expected job gains to land at around 185,000, according to several reports. After 11 months of aggressive rate hikes from the Federal Reserve, the experts were naturally expecting the economy’s job gains to slow as higher borrowing costs percolated through the economy,…

Read More

Week of January 29, 2023 What was really behind the 367% move BuzzFeed (Nasdaq: BZFD) made last week? (Hint: it’s probably not what you think but keep reading to find out…) If you were an owner of BuzzFeed (Nasdaq: BZFD) stock, last week was very good to you… Last Thursday, January 26th, 2023, the stock soared on news that BuzzFeed was partnering with OpenAI to generate content, as well as news of a separate deal with Facebook parent company, Meta. But what’s really behind the 367% move that BuzzFeed (Nasdaq: BZFD) made last week? Hint: Could it be that BuzzFeed…

Read More

1/29/23 Greetings Readers, Biotech companies are quickly becoming an essential part of the modern economy. Developing cutting-edge products and treatments, they are revolutionizing how we view and approach health and healing. In fact, there are several reasons why one might want to closely watch biotech companies: Biotechnology companies often have a large potential for growth, as they are often working on developing new and innovative products and treatments. They are often at the forefront of advances in medicine and technology, which can lead to significant breakthroughs. Biotech companies are often focused on developing treatments for serious or life-threatening illnesses, which…

Read More

1/24/23 Greetings Readers, We’ve got zero time to waste today. At 8:00PM EST tonight, I’m bringing a past champ back to your attention. Right now, I’m putting the finishing touches on your full report. Until that time, chew on these key details: #1. This is a low float idea. With so few shares available for trading in the public sphere, volatility could crop up at any moment for this Nasdaq profile. #2. There have been a ton of positive company updates/news that could signal that the company might not fly under Wall Street’s radar for much longer. #3. Explosive intraday…

Read More

1/22/23 Greetings Readers, 2023. Talk about a scalding start. To date, we’ve delivered 3 different alerts that have gone on to produce short term, double-digit rips. Were you paying attention? Here’s a quick recap: January 3rd (GNPX): Opening at $1.50 and surging to a $1.94 high the next day, GNPX ran approximately 29% just like that. January 4th (SYTA): A little bit slower to develop, SYTA has now made an approximate 35% move from an open of $.215 to a January 18th high of $.292. January 9th (CMND): Another quick popper, CMND blasted from a $3.75 open to a $5.10…

Read More